Diagnostic And Treatment Protocol Adopted by Private Practitioners of Surat City for Drug Resistant Tuberculosis Patients
Introduction: This study explores the practices adopted by Private Practitioners for diagnosis and management of Drug Resistant Tu- berculosis patients in Surat city of Western India. Methodology: In this descriptive cross sectional study of Private Physicians of Surat city were selected randomly fr...
Gespeichert in:
Veröffentlicht in: | National journal of community medicine 2015-09, Vol.6 (3) |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction: This study explores the practices adopted by Private Practitioners for diagnosis and management of Drug Resistant Tu- berculosis patients in Surat city of Western India. Methodology: In this descriptive cross sectional study of Private Physicians of Surat city were selected randomly from IMA Surat member list. A pre-test questionnaire including Profile of the doc- tor, Profile of patients suspected for MDR TB, Diagnostic & Treat- ment practices and Follow up issues was used to collect data. Data Analysis was done using Epi-info software calculating descriptive statistics. Results: Most common investigative methods used by private phy- sicians to diagnose MDR TB were sputum microscopy, x-ray chest and sputum culture. Commonly used second line drugs for MDR TB patients were Fluoroquinolones, Aminoglycosides and Ethion- amide. Nearly three forth physicians preferred 4 or more drug combination for MDR TB treatment. Most of them preferred 2 or 3 second line drugs in their prescriptions. Common investigations preffered by them during follow up were Sputum AFB, Culture and Chest X-Ray. Conclusion: Compliance to recommended standards of MDR TB management was common among the private physicians but quite a few were unacceptable in context of WHO recommendations. There is need to streamline these protocols according to the general guideline for MDR TB management. |
---|---|
ISSN: | 0976-3325 2229-6816 |